BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Onorato L, Pisaturo M, Camaioni C, Grimaldi P, Codella AV, Calò F, Coppola N. Risk and Prevention of Hepatitis B Virus Reactivation during Immunosuppression for Non-Oncological Diseases. J Clin Med 2021;10:5201. [PMID: 34768721 DOI: 10.3390/jcm10215201] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Capkin E, Yazıcı A, Karkucak M, Durmaz Y, Toprak M, Ataman Ş, Şahin N, Cüzdan N, Kasapoğlu Aksoy M, Önder ME, Serdaroglu Beyazal M, Mesci N, Baykul M, Alkan Melikoğlu M, Alkan H, Dulgeroglu D, Cengiz AK, Nas K, Balevi Batur E, Çalışkan Uçkun A, Deveci H, Erol K, Albayrak Gezer İ, Akgöl G, Duruöz MT, Küçükakkaş O, Sarıkaya S, Rezvani A, Atan T, Göğüş F, Çağlayan G, Keskin Y, Bulut Keskin AS, Öz N, Yılmaz G. Evaluation of hepatitis serology and frequency of viral reactivation in patients with inflammatory arthritis receiving biologic agents: a multicenter observational study. Rheumatol Int 2022. [PMID: 36063169 DOI: 10.1007/s00296-022-05169-2] [Reference Citation Analysis]
2 Al-masoodi BAH, Reem A, Bahaj SS, Al-haimi RM, Al-shamahy HA, Abuasba N, Al-shawkany AM, Kumal JPP. Prevalence of Occult Hepatitis B Virus among Hemodialysis Patients in Sana'a City. IJID Regions 2022. [DOI: 10.1016/j.ijregi.2022.09.004] [Reference Citation Analysis]
3 Yuan WZ, Fu T. Liver Dysfunction in COVID-19: From Onset to Recovery. Semin Liver Dis 2022;42:151-8. [PMID: 35738256 DOI: 10.1055/s-0042-1745871] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Yuan C, Peng J, Xia R, He J, Qiu T, Yao Y. Reactivation of Occult Hepatitis B Virus Infection During Long-Term Entecavir Antiviral Therapy. Front Microbiol 2022;13:865124. [DOI: 10.3389/fmicb.2022.865124] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]